These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12612105)

  • 1. Adherence to HIV medications in a cohort of men who have sex with men: impact of September 11th.
    Halkitis PN; Kutnick AH; Rosof E; Slater S; Parsons JT
    J Urban Health; 2003 Mar; 80(1):161-6. PubMed ID: 12612105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states.
    Halkitis PN; Kutnick AH; Slater S
    J Health Psychol; 2005 Jul; 10(4):545-58. PubMed ID: 16014391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women.
    Simoni JM; Pantalone DW; Plummer MD; Huang B
    Health Psychol; 2007 Jul; 26(4):488-95. PubMed ID: 17605569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
    Wagner GJ; Rabkin JG
    AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.
    Wang X; Wu Z
    AIDS; 2007 Dec; 21 Suppl 8():S149-55. PubMed ID: 18172384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
    Moore DM; Hogg RS; Yip B; Wood E; Harris M; Montaner JS
    HIV Med; 2006 Jul; 7(5):311-6. PubMed ID: 16945076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of HIV/AIDS patients who have excellent adherence to HAART.
    Malcolm SE; Ng JJ; Rosen RK; Stone VE
    AIDS Care; 2003 Apr; 15(2):251-61. PubMed ID: 12856346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
    Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F
    Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reframing HIV adherence as part of the experience of illness.
    Golub SA; Indyk D; Wainberg ML
    Soc Work Health Care; 2006; 42(3-4):167-88. PubMed ID: 16687381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: patient satisfaction and implications for adherence.
    Jordan J; Cahn P; Goebel F; Matheron S; Bradley C; Woodcock A
    AIDS Patient Care STDS; 2005 Jan; 19(1):9-18. PubMed ID: 15665631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.
    Falade-Nwulia O; Seaberg EC; Snider AE; Rinaldo CR; Phair J; Witt MD; Thio CL
    Ann Intern Med; 2015 Nov; 163(9):673-80. PubMed ID: 26457744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.
    Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
    Med Decis Making; 2008; 28(3):359-76. PubMed ID: 18349433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.